Recurrence of conjunctival goblet cells after discontinuation of dupilumab in a patient with dupilumab-related conjunctivitis
Publication date
2020-02-01
Authors
Voorberg, A N
den Dunnen, W F A
Wijdh, R H J
de Bruin-Weller, Marjolein
Schuttelaar, M L A
Editors
Advisors
Supervisors
Document Type
Letter
Metadata
Show full item recordCollections
License
taverne
Abstract
Keywords
Adult, Antibodies, Monoclonal, Humanized/adverse effects, Conjunctiva/drug effects, Conjunctivitis/chemically induced, Dermatitis, Atopic/drug therapy, Female, Goblet Cells/pathology, Humans, Interleukin-4 Receptor alpha Subunit/drug effects, Taverne, Case Reports, Letter
Citation
Voorberg, A N, den Dunnen, W F A, Wijdh, R H J, de Bruin-Weller, M S & Schuttelaar, M L A 2020, 'Recurrence of conjunctival goblet cells after discontinuation of dupilumab in a patient with dupilumab-related conjunctivitis', JEADV : journal of the European Academy of Dermatology and Venereology, vol. 34, no. 2, pp. e64-e66. https://doi.org/10.1111/jdv.15914